Angiogenesis, Inflammation & Therapeutics | Online ISSN  2207-872X
CONFERENCE ABSTRACT   (Open Access)

Cancer-Associated Fibroblasts as Potential Therapeutic Targets in Head and Neck Cancer

Prof. Dr. Ian Paterson

+ Author Affiliations

Journal of Angiotherapy 6(3) 709-709 https://doi.org/10.25163/angiotherapy.6312C

Submitted: 24 December 2022  Revised: 24 December 2022 

Abstract


It is now recognised that non-malignant components within the tumour microenvironment (TME) also influence tumour development and progression. Cancer-associated fibroblasts (CAFs) are often the most abundant cell type within the tumour stroma. Here, they actively participate in the reciprocal communication between tumour cells and other host cells in the TME to create a tumour-permissive microenvironment in a number of epithelial tumours, including those of the head and neck. CAFs share many characteristics with fibroblasts found within healing wounds and demonstrate a perpetually “active,” alpha-smooth muscle actin positive phenotype. In this talk, I will describe the functional role of CAFs in head and neck cancers (oral and nasopharyngeal carcinomas) and discuss the signalling pathways involved in CAF activation. Finally, the possibility of targeting CAFs therapeutically will be discussed.

References


Full Text
Export Citation

View Dimensions


View Plumx



View Altmetric



0
Save
0
Citation
517
View
0
Share